Experts Sought Research on GLP-1 and Eating Disorders
Behavioral health experts are calling for more study on how GLP-1 drugs may affect those with eating disorders.
Updated on Oct. 7, 2026 in Weight Loss
Live Poll
Do you trust the current medical screening processes for accessing weight-loss medications?
Behavioral health experts have requested more research into the impact of GLP-1 medications on individuals with or predisposed to eating disorders. This appeal comes as concerns grow regarding how the accessibility of these drugs through telehealth may affect mental health.
Why it matters
Advocates fear that current marketing and ease of access to GLP-1 drugs could pose significant risks for vulnerable populations. The shift toward weight-loss medications requires deeper investigation to ensure patient safety and mental well-being.
Professional entities and experts in the field have highlighted the need for data on GLP-1 outcomes in patients with eating disorders. The investigation remains preliminary as current research focuses on weight loss, sexual health, and hair growth.
The players
Serena Williams
Professional athlete who features in advertisements for a telehealth company prescribing GLP-1 medications.
The Renfrew Center
Philadelphia-based facility employing psychologists who specialize in the treatment of eating disorders.
Gabriela Ponce
A New York City resident who experienced the influence of diet culture in the 1990s and has been in eating disorder recovery for over a decade.
The details
GLP-1 medications are increasingly marketed to the public through social media and various telehealth companies. Some of these platforms provide access to the drugs with limited medical and mental health screenings, raising concerns about the potential for adverse psychological outcomes. Experts argue that rigorous protocols are necessary to identify patients at risk of developing disordered eating patterns before prescribing these treatments.
Timeline
Diet culture influenced Gabriela Ponce during the 1990s.
Gabriela Ponce began her recovery from an eating disorder over a decade ago.
The cultural shift toward thinness via GLP-1 medications accelerated a couple years ago.
Health Landscape
The rise of direct-to-consumer telehealth has fundamentally changed how patients access weight-loss medications like GLP-1s. This development forces a re-evaluation of the historical separation between metabolic health interventions and psychiatric screening standards.
If you have a history of eating disorders or body image concerns, it is vital to have a detailed conversation with your doctor before starting any GLP-1 weight-loss medication. Ensure your provider conducts a thorough mental health screening to evaluate whether these treatments are appropriate for your specific health history.
The takeaway
The rapid expansion of weight-loss drugs via telehealth warrants caution for those with histories of disordered eating. Always prioritize a comprehensive mental health assessment with your physician to ensure that any chosen treatment plan supports your overall well-being.
Further reading
For more information on navigating weight management safely, visit Weight Loss.
Source note: This article includes information reported by WHYY.
Live Poll
Do you trust the current medical screening processes for accessing weight-loss medications?
